Sangamo Therapeutics, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €261.28M +47.8% €101.61M +173.0% 38.9% +0.18 pp €111.82M +130.8% 42.8% +0.15 pp
    (estimated) €176.73M +71.1% €37.21M -244.1% 21.1% +0.46 pp €48.45M -530.3% 27.4% +0.38 pp
    (estimated) €103.32M +151.0% -€25.83M -67.2% -25.0% +1.7 pp -€11.26M -79.9% -10.9% +1.3 pp
    (estimated) €41.16M -33.3% -€78.74M +25.5% -191.3% -0.90 pp -€56.04M +65.1% -136.1% -0.81 pp
    (estimated) €61.73M +25.2% -€62.74M -24.9% -101.6% +0.68 pp -€33.95M -40.5% -55.0% +0.61 pp
    €49.30M -67.2% -€83.54M -62.0% -169.4% -0.23 pp -€57.04M -67.2% -115.7% -0.0012 pp
    €150.32M +58.3% -€219.92M +34.1% -146.3% +0.26 pp -€173.74M +0.1% -115.6% +0.67 pp
    €94.93M +0.5% -€164.00M +7.8% -172.8% -0.12 pp -€173.54M -3.1% -182.8% +0.069 pp
    €94.42M -6.3% -€152.08M +47.2% -161.1% -0.59 pp -€179.10M -213.8% -189.7% -3.5 pp
    €100.81M +15.4% -€103.31M +59.8% -102.5% -0.28 pp €157.45M -249.2% 156.2% +2.8 pp
    €87.37M +21.3% -€64.67M +11.0% -74.0% +0.069 pp -€105.53M -254.2% -120.8% -2.2 pp
    €72.03M +131.0% -€58.29M +25.2% -80.9% +0.68 pp €68.42M +437.3% 95.0% +0.54 pp
    €31.19M +88.6% -€46.54M -23.8% -149.2% +2.2 pp €12.73M -122.9% 40.8% +3.8 pp
    €16.54M -51.0% -€61.12M +76.1% -369.6% -2.7 pp -€55.57M +108.1% -336.0% -2.6 pp
    €33.72M -13.8% -€34.72M +54.1% -102.9% -0.45 pp -€26.71M +519.5% -79.2% -0.68 pp
    €39.12M +90.1% -€22.53M -0.8% -57.6% +0.53 pp -€4.31M -73.5% -11.0% +0.68 pp
    €20.58M +11.4% -€22.71M +19.6% -110.3% -0.075 pp -€16.25M +158.9% -78.9% -0.45 pp
    €18.47M +109.9% -€18.99M -37.7% -102.8% +2.4 pp -€6.28M -70.9% -34.0% +2.1 pp
    €8.80M -50.4% -€30.49M +43.8% -346.4% -2.3 pp -€21.60M +9.0% -245.4% -1.3 pp
    €17.75M -6.2% -€21.20M +33.7% -119.5% -0.36 pp -€19.82M +296.2% -111.7% -0.85 pp
    €18.92M +37.1% -€15.85M -23.5% -83.8% +0.66 pp -€5.00M -64.7% -26.4% +0.76 pp
    €13.81M +77.9% -€20.73M +13.1% -150.1% +0.86 pp -€14.16M +13.0% -102.6% +0.59 pp
    €7.76M +15.4% -€18.32M +20.2% -236.1% -0.095 pp -€12.54M +4.2% -161.6% +0.17 pp
    €6.73M +217.4% -€15.24M +34.4% -226.6% +3.1 pp -€12.03M +287.4% -178.9% -0.32 pp
    €2.12M +88.9% -€11.34M -3.8% -535.1% +5.2 pp -€3.11M -64.1% -146.6% +6.2 pp
    €1.12M -49.0% -€11.79M +32.4% -1,050.8% -6.5 pp -€8.65M +37.5% -771.1% -4.9 pp
    €2.20M -40.6% -€8.90M -64.9% -404.5% +2.8 pp -€6.29M -23.2% -286.0% -0.65 pp
    €3.70M -11.1% -€25.39M +17.9% -685.3% -1.7 pp -€8.19M +104.1% -221.1% -1.2 pp
    €4.17M +42.3% -€21.54M +178.5% -516.9% -2.5 pp -€4.01M +568.2% -96.3% -0.76 pp
    €2.93M +56.0% -€7.73M +138.6% -264.1% -0.91 pp -€600.48K -66.5% -20.5% +0.75 pp
    €1.88M -€3.24M -172.7% -€1.79M -95.5%

    Notifications